LP14353-4
Amantadine
Active
Description
An antiviral that is used in the prophylactic or symptomatic treatment of influenza A. It is also used as an antiparkinsonian agent, to treat extrapyramidal reactions, and for postherpetic neuralgia. The mechanisms of its effects in movement disorders are not well understood but probably reflect an increase in synthesis and release of dopamine, with perhaps some inhibition of dopamine uptake. Source: National Library of Medicine, MeSH 2006
Basic Part Properties
- Part Display Name
- Amantadine
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2000-05-04
- Construct for LOINC Short Name
- Amantadine
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP14353-4 - ConceptMap translate
- https:
//fhir.loinc.org/ConceptMap/$translate?system=http: //loinc.org&code=LP14353-4
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | 金刚烷胺 Synonyms: 三环癸胺; |
| fr-CA | French (Canada) | Amantadine |
| et-EE | Estonian (Estonia) | Amantadiin |
| es-ES | Spanish (Spain) | Amantadina |
| it-IT | Italian (Italy) | Amantadina |
| tr-TR | Turkish (Turkey) | Amantadin |
| ru-RU | Russian (Russian Federation) | Амантадин |
| nl-NL | Dutch (Netherlands) | amantadine |
| fr-BE | French (Belgium) | Amantadine |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright